Post-marketing Surveillance of Atrovent® Inhalets in Chronic Obstructive Pulmonary Disease
NCT02233894
·
clinicaltrials.gov ↗
COMPLETED
Status
526
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Atrovent® - inhalets
Sponsor
Boehringer Ingelheim